Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 72

1.

Metabolic consequences of perioperative oral carbohydrates in breast cancer patients - an explorative study.

Lende TH, Austdal M, Bathen TF, Varhaugvik AE, Skaland I, Gudlaugsson E, Egeland NG, Lunde S, Akslen LA, Jonsdottir K, Janssen EAM, Søiland H, Baak JPA.

BMC Cancer. 2019 Dec 4;19(1):1183. doi: 10.1186/s12885-019-6393-7.

2.

Detection of disseminated tumor cells in bone marrow predict late recurrences in operable breast cancer patients.

Tjensvoll K, Nordgård O, Skjæveland M, Oltedal S, Janssen EAM, Gilje B.

BMC Cancer. 2019 Nov 21;19(1):1131. doi: 10.1186/s12885-019-6268-y.

3.

Influence of pre-operative oral carbohydrate loading vs. standard fasting on tumor proliferation and clinical outcome in breast cancer patients ─ a randomized trial.

Lende TH, Austdal M, Varhaugvik AE, Skaland I, Gudlaugsson E, Kvaløy JT, Akslen LA, Søiland H, Janssen EAM, Baak JPA.

BMC Cancer. 2019 Nov 8;19(1):1076. doi: 10.1186/s12885-019-6275-z.

4.

Panoptic View of Prognostic Models for Personalized Breast Cancer Management.

Saini G, Mittal K, Rida P, Janssen EAM, Gogineni K, Aneja R.

Cancers (Basel). 2019 Sep 7;11(9). pii: E1325. doi: 10.3390/cancers11091325. Review.

5.

Prognostic value and reproducibility of different microscopic characteristics in the WHO grading systems for pTa and pT1 urinary bladder urothelial carcinomas.

Kvikstad V, Mangrud OM, Gudlaugsson E, Dalen I, Espeland H, Baak JPA, Janssen EAM.

Diagn Pathol. 2019 Aug 14;14(1):90. doi: 10.1186/s13000-019-0868-3.

6.

Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study.

Bhattarai S, Klimov S, Mittal K, Krishnamurti U, Li XB, Oprea-Ilies G, Wetherilt CS, Riaz A, Aleskandarany MA, Green AR, Ellis IO, Cantuaria G, Gupta M, Manne U, Agboola J, Baskovich B, Janssen EAM, Callagy G, Walsh EM, Mehta A, Dogra A, Shet T, Gajaria P, Traina T, Nggada HA, Omonisi A, Ahmed SA, Rakha EA, Rida P, Aneja R.

Cancers (Basel). 2019 Jul 17;11(7). pii: E995. doi: 10.3390/cancers11070995.

7.

Validation study of MARCKSL1 as a prognostic factor in lymph node-negative breast cancer patients.

Egeland NG, Austdal M, van Diermen-Hidle B, Rewcastle E, Gudlaugsson EG, Baak JPA, Skaland I, Janssen EAM, Jonsdottir K.

PLoS One. 2019 Mar 11;14(3):e0212527. doi: 10.1371/journal.pone.0212527. eCollection 2019.

8.

Assessing the prognostic value of PAX2 and PTEN in endometrial carcinogenesis.

Rewcastle E, Varhaugvik AE, Gudlaugsson E, Steinbakk A, Skaland I, van Diermen B, Baak JP, Janssen EAM.

Endocr Relat Cancer. 2018 Dec 1;25(12):981-991. doi: 10.1530/ERC-18-0106.

PMID:
30400021
9.

Gain of Chromosomal Region 3q26 as a Prognostic Biomarker for High-Grade Cervical Intraepithelial Neoplasia: Literature Overview and Pilot Study.

Koeneman MM, Ovestad IT, Janssen EAM, Ummelen M, Kruitwagen RFPM, Hopman AH, Kruse AJ.

Pathol Oncol Res. 2019 Apr;25(2):549-557. doi: 10.1007/s12253-018-0480-y. Epub 2018 Oct 25. Review.

10.

Expression profiling and intracellular localization studies of the novel Proline-, Histidine-, and Glycine-rich protein 1 suggest an essential role in gastro-intestinal epithelium and a potential clinical application in colorectal cancer diagnostics.

Oltedal S, Skaland I, Maple-Grødem J, Tjensvoll K, Janssen EAM, Gilje B, Smaaland R, Heikkilä R, Nordgård O.

BMC Gastroenterol. 2018 Feb 7;18(1):26. doi: 10.1186/s12876-018-0752-8.

11.

Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients.

Helland T, Henne N, Bifulco E, Naume B, Borgen E, Kristensen VN, Kvaløy JT, Lash TL, Alnæs GIG, van Schaik RH, Janssen EAM, Hustad S, Lien EA, Mellgren G, Søiland H.

Breast Cancer Res. 2017 Nov 28;19(1):125. doi: 10.1186/s13058-017-0916-4.

12.

Amplified centrosomes and mitotic index display poor concordance between patient tumors and cultured cancer cells.

Mittal K, Choi DH, Ogden A, Donthamsetty S, Melton BD, Gupta MV, Pannu V, Cantuaria G, Varambally S, Reid MD, Jonsdottir K, Janssen EA, Aleskandarany MA, Ellis IO, Rakha EA, Rida PC, Aneja R.

Sci Rep. 2017 Mar 8;7:43984. doi: 10.1038/srep43984.

13.

Quality assurance of human papillomavirus (HPV) testing in the implementation of HPV primary screening in Norway: an inter-laboratory reproducibility study.

Engesæter B, van Diermen Hidle B, Hansen M, Moltu P, Staby KM, Borchgrevink-Persen S, Vintermyr OK, Lönnberg S, Nygård M, Janssen EA, Castle PE, Christiansen IK.

BMC Infect Dis. 2016 Nov 24;16(1):698.

14.

Epigenome-wide DNA methylation patterns associated with fatigue in primary Sjögren's syndrome.

Brække Norheim K, Imgenberg-Kreuz J, Jonsdottir K, Janssen EA, Syvänen AC, Sandling JK, Nordmark G, Omdal R.

Rheumatology (Oxford). 2016 Jun;55(6):1074-82. doi: 10.1093/rheumatology/kew008. Epub 2016 Mar 10.

PMID:
26966136
15.

The Role of MicroRNAs as Predictors of Response to Tamoxifen Treatment in Breast Cancer Patients.

Egeland NG, Lunde S, Jonsdottir K, Lende TH, Cronin-Fenton D, Gilje B, Janssen EA, Søiland H.

Int J Mol Sci. 2015 Oct 14;16(10):24243-75. doi: 10.3390/ijms161024243. Review.

16.

Prediction of spontaneous regression of cervical intraepithelial neoplasia lesions grades 2 and 3 by proteomic analysis.

Uleberg KE, Ovestad IT, Munk AC, Brede C, van Diermen B, Gudlaugsson E, Janssen EA, Hjelle A, Baak JP.

Int J Proteomics. 2014;2014:129064. doi: 10.1155/2014/129064. Epub 2014 Jun 15.

17.

Prognostic comparison of proliferation markers and World Health Organization 1973/2004 grades in urothelial carcinomas of the urinary bladder.

Mangrud OM, Gudlaugsson E, Skaland I, Tasdemir I, Dalen I, van Diermen B, Baak JP, Janssen EA.

Hum Pathol. 2014 Jul;45(7):1496-503. doi: 10.1016/j.humpath.2014.03.001. Epub 2014 Mar 26.

PMID:
24796506
18.

Prognostic value of gene signatures and proliferation in lymph-node-negative breast cancer.

Jonsdottir K, Assmus J, Slewa A, Gudlaugsson E, Skaland I, Baak JP, Janssen EA.

PLoS One. 2014 Mar 5;9(3):e90642. doi: 10.1371/journal.pone.0090642. eCollection 2014.

19.

Reproducibility and prognostic value of WHO1973 and WHO2004 grading systems in TaT1 urothelial carcinoma of the urinary bladder.

Mangrud OM, Waalen R, Gudlaugsson E, Dalen I, Tasdemir I, Janssen EA, Baak JP.

PLoS One. 2014 Jan 7;9(1):e83192. doi: 10.1371/journal.pone.0083192. eCollection 2014.

20.

The prognostic value of mitotic activity index (MAI), phosphohistone H3 (PPH3), cyclin B1, cyclin A, and Ki67, alone and in combinations, in node-negative premenopausal breast cancer.

Klintman M, Strand C, Ahlin C, Beglerbegovic S, Fjällskog ML, Grabau D, Gudlaugsson E, Janssen EA, Lövgren K, Skaland I, Bendahl PO, Malmström P, Baak JP, Fernö M.

PLoS One. 2013 Dec 4;8(12):e81902. doi: 10.1371/journal.pone.0081902. eCollection 2013.

Supplemental Content

Loading ...
Support Center